A novel synthetic lethal target for ATM inhibitors in pancreatic cancer

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic cancer treatment.

Why do we blush, and what are the underlying mechanisms of blushing? Research aims to find out

Researchers investigated the neural substrates and mental processes underlying blushing in response to self-observation.

July 22, 2024

New technique could one day be used to target glioblastoma

Tackling brain cancer is complicated, but groundbreaking new research could help add another tool to the cancer-fighting arsenal.

July 18, 2024

Europe gears up for future pandemics with AI-powered “PAIR” project

The new EU-funded five-year project PAIR just kicked off in Copenaghen with the participation of 20 partners from 7 countries.

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.